Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Isabel Arrillaga-Romany, M.D.

Concepts (164)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Isabel Arrillaga-Romany's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Isabel Arrillaga-Romany has written about over time.
Angiogenesis Inhibitors, 3 publications between 2013 and 2021, average publication date August 2016. Neurotoxicity Syndromes, 5 publications between 2012 and 2023, average publication date May 2017. Antigens, CD19, 1 publications between 2017 and 2017, average publication date August 2017. Receptors, Antigen, T-Cell, 1 publications between 2017 and 2017, average publication date August 2017. Antineoplastic Agents, 9 publications between 2012 and 2024, average publication date July 2018. Brain Diseases, 1 publications between 2019 and 2019, average publication date January 2019. Critical Pathways, 1 publications between 2019 and 2019, average publication date January 2019. Receptors, Dopamine D5, 2 publications between 2018 and 2020, average publication date June 2019. Glioblastoma, 9 publications between 2013 and 2023, average publication date July 2019. Imidazoles, 3 publications between 2018 and 2024, average publication date February 2021. Proto-Oncogene Proteins B-raf, 1 publications between 2021 and 2021, average publication date February 2021. Brain Neoplasms, 20 publications between 2013 and 2024, average publication date June 2021. Neoplasm Recurrence, Local, 6 publications between 2019 and 2024, average publication date June 2021. Pyridines, 4 publications between 2018 and 2024, average publication date August 2021. Receptors, Dopamine D2, 2 publications between 2018 and 2024, average publication date August 2021. Isocitrate Dehydrogenase, 7 publications between 2018 and 2024, average publication date August 2021. Pyrimidines, 5 publications between 2018 and 2024, average publication date May 2022. Mutation, 13 publications between 2018 and 2024, average publication date May 2022. Glioma, 14 publications between 2018 and 2024, average publication date October 2022. Histones, 7 publications between 2020 and 2024, average publication date June 2023.

To see the data from this visualization as text, click here.
Arrillaga-Romany's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (164)
Explore
_
Co-Authors (94)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.